Both in Pharmaceuticals
Grace Therapeutics vs NanoViricides
Over the past year GRCE returned −37.5% and NNVC returned +2.0%; their daily moves had a correlation of 0.07.
GRCE −37.5% NNVC +2.0%Growth of $1, one year, split-adjusted
| Metric | GRCE | NNVC |
|---|---|---|
| Price | $1.97 | $1.51 |
| Market cap | $41.4M | $38.5M |
| Today | −0.51% | +2.03% |
| 1 month | −7.9% | −1.3% |
| 6 months | −54.3% | +12.7% |
| Year to date | −43.1% | +33.6% |
| 1 year | −38.8% | −0.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $13.8M | $2.8M |
| Dividend yield | — | — |
| Volatility (60d) | 39.4% | 86.7% |
| Short % of float | 11.4% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).